Dr. Alice Jacobs, CEO of IntelligentMDx, Honored as a 2012 Mass High Tech Woman to Watch
CAMBRIDGE, Mass., March 6, 2012 /PRNewswire/ -- Dr. Alice Jacobs, Chairman and CEO of IntelligentMDx (IMDx), has been named a 2012 Woman to Watch by Mass High Tech. This is the 9th year Mass High Tech, The Voice of New England Innovation, has been honoring New England women for their contributions to their technology sectors and their positions as role models in the community. The Mass High Tech Women to Watch are highly motivated with outstanding records of accomplishment and command attention as they continue to shape the future of their industries.
"It is important for young women who aspire to become powerful leaders to have role models to emulate," says Dr. Alice Jacobs. "I am honored to receive this distinction along with other great women."
Under the leadership of Dr. Jacobs, IMDx designs, develops, and manufactures clinically relevant molecular diagnostics for rapid and accurate detection of diseases. In 2011, IMDx released two CE-marked diagnostic kits, which are being distributed globally by Abbott, targeting two of the most threatening healthcare-associated infections, Clostridium difficile, and vancomycin-resistant enterococci. Diagnostic tests for Group B streptococcus and Influenza A/B and RSV are scheduled to obtain CE-marking and launch in the spring of 2012. The IMDx pipeline also includes additional assays targeting oncology, human genetics and companion diagnostics.
IMDx employs experts from diverse backgrounds including financial, legal, scientific, and medical, and is run in a unique manner such that all are involved in product development from initial concept stages to commercialization. Dr. Jacobs works hard to ensure the highest quality products are produced at IMDx and accurately reflect the needs of the global medical community. Through the creation of IMDx, Dr. Jacobs is achieving her goal of improving the relationship between patients, physicians and diagnostics. Dr. Jacobs is a woman to watch as IMDx grows and expands its menu offerings, becoming a larger player in the molecular diagnostics industry.
Based in Cambridge, MA, IMDx (www.IntelligentMDx.com) is an innovative company that designs, develops and manufactures molecular diagnostic products. IMDx has developed molecular solutions that are clinically impactful and competitively differentiated for a range of disease areas for current and next generation systems, including targets in infectious diseases, oncology and genetics. IMDx's expertise spans evolutionary biology, bioinformatics, microbiology, chemistry and molecular biology. These capabilities are harnessed by IMDx's proprietary bioinformatics and product development processes allowing for the rapid design and development of tests to meet clinical needs.
Contact: Renda Hawwa, +1-617-871-6405
More by this Source
IntelligentMDx Receives FDA Clearance for IMDx Flu A/B and RSV for Abbott m2000 assay
Sep 10, 2013, 16:28 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.